Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04741438
Title Efficacy of the Combination of Nivolumab and Ipilimumab as a Treatment in Patients With Sarcoma of Rare Subtype (RAR-Immune)
Acronym RAR-Immune
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Centre Leon Berard
Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.